UROTENSIN相关论文
AIM:To investigate urotensin-Ⅱ(UⅡ) and its effects on tumor necrosis factor(TNF)-α and interleukin(IL)-1β in early a......
Objective The goal of this study was to examine the association between urotensin Ⅱ (U Ⅱ) concentration and the severi......
Objective To determine the plasma urolensin Ⅱ(UII) levels in various types of coronary heart disease and to clarify how......
AIM: To investigated the effects of urotensin Ⅱ(UII) on hepatic insulin resistance in Hep G2 cells and the potential me......
鱼尾加压素Ⅱ（ｕｒｏｔｅｎｓｉｎⅡ，ＵⅡ）最早是从鱼的脊髓中分离出来的生长抑素样环肽，近年已从人体中克隆出来，并发现它主要分布于神经和心血管组织。最近......
Objective: To localize where urocortin is expressed in human tissue in an attempt to study its physiological functions. ......
应用半定量逆转录-多聚酶链反应法,观察尾加压素（urotensinⅡ,UⅡ）对培养的新生SD大鼠心肌细胞内皮型一氧化氮合酶（endothelial nitri......
尾加压素II (urotensin ,UII)是具有广泛生物学效应的血管活性肽 ,在心血管系统的稳态调节和心血管疾病的发生发展机制中具有十分......
尾加压素Ⅱ (urotensinⅡ ,UⅡ )最早是从鱼的脊髓中分离出来的生长抑素样环肽 ,是目前所知最强的缩血管活性物质。随后 ,Ames等发......
Urotensin Ⅱ inhibits electrical activity of hippocampal CA1 neurons by potentiating the GABA_A recep
Objective To examine the effects of urotensin Ⅱ (UII) on the discharges of neurons in CA1 area of hipp-ocampal slices b......
Urotensin Ⅱ inhibits electrical activity of hippocampal CA1 neurons by potentiating the GABA_A recep
Objective To examine the effects of urotensin Ⅱ (UII) on the discharges of neurons in CA1 area of hipp-ocampal slices b......
目的 :研究尾加压素Ⅱ (urotensinⅡ ,UⅡ )对大鼠主动脉一氧化氮合酶 (nitricoxidesynthase ,NOS) /一氧化氮 (nitricoxide,NO)系......
Aim:To study the effects of urotensin Ⅱ(UⅡ)on the carotid sinus baroreflex(CSB).Methods:The functional curve of carot......
Aim:To study the effects of urotensin Ⅱ(UⅡ)on the carotid sinus baroreflex(CSB).Methods:The functional curve of carot......
Human urotension-Ⅱwas synthesized efficiently on Wang resin under microwave irradiation using Fmoc/tBu orthogonal prote......
目的动态观察内源性尾加压素Ⅱ(urotensin Ⅱ, UⅡ)在慢性低氧高二氧化碳性肺动脉高压大鼠不同节段肺细小动脉的表达,以探讨其在肺......
目的：观察尾加压素Ⅱ（UⅡ）及其受体UT在慢性低Q高C02肺动脉高压大鼠右心室的表达。方法：健康SD大鼠20只随机分成正常对照组和低氧高二......
AIM: To investigated the effects of urotensin Ⅱ(UII) on hepatic insulin resistance in Hep G2 cells and the potential me......
目的研究哮喘气道重塑大鼠尾加压素Ⅱ（UⅡ）和转化生长因子（TGF）-β1的表达变化，探讨UⅡ对哮喘大鼠气道平滑肌细胞（ASMC）中TGF-β1表达的调......
促肾上腺皮质激素释放因子（CRF）家族包括CRF，硬骨鱼紧张肽urotensin Ⅰ，蛙皮降压肽（sauvagine），urocortin，以及新近发现的urocortin Ⅱ和ur......
目的研究全麻诱导对患者血浆尾加压素Ⅱ和肾素、血管紧张素活性的影响.方法 20例全麻手术患者,于麻醉诱导前20分钟和诱导后10分钟......
目的研究人尾加压素(UⅡ)刺激人血管内皮细胞(HVEC)分泌肾上腺髓质素(Adm)的机制.方法以不同浓度的UⅡ(10-10、10-9、10-8、10-7mo......
尾加压素Ⅱ（urotensin Ⅱ，UII）是1985年自硬骨鱼的脊髓尾部神经分泌系统分离出来的一种生长抑素样环肽，属于神经肽范围。近年已从人体......
目的观察姜黄素对哮喘大鼠气道重塑及尾加压素II（U11）表达的影响。方法大鼠间隔7d共2次ip给以卵清蛋白（OVA）／AI（OH）3，第15天雾化吸入OVA激......
尾加压素Ⅱ（Urotensin Ⅱ，UⅡ）是一种具有广泛生物学效应的血管活性肽。它最初是从鱼的脊髓尾垂体中分离出来的生长抑素样环肽。1999......
目的 采用单核苷酸多态性（single mucleotide polymorphism,SNP)标记，在以往中国北方汉族人群2型糖尿病相关基因定位区域（1p36.33-p3......
尾加压素Ⅱ（UrotensinⅡ，UⅡ）是迄今为止发现的最强的缩血管物质，主要分布于心血管系统及神经系统。本实验观察UⅡ对大鼠心功能的影响，......
UrotensinⅡ被认为是目前最有效的人用血管收缩药，虽然其病理生理机理尚不明确，但其在合并慢性肝病的门静脉高压症的发病机理中具有......
目的：探讨Urotensin Ⅱ（UⅡ）在急性肝衰竭（acute liver failure,ALF）小鼠肝组织中的表达及损伤作用.方法：♂Balb/c小鼠随机分成4组（每组6......
目的观察不同浓度UrotensinⅡ（UⅡ）对心力衰竭大鼠心功能的影响，及特异性的PKA抑制剂（KT5720）对UⅡ作用于心力衰竭大鼠心脏效应的影响。......
Objective To determine the plasma urolensin Ⅱ(UⅡ) levels in various types of coronary heart disease and to clarify how......
Objective The goal of this study was to examine the association between urotensin Ⅱ (U Ⅱ) concentration and the severi......
